Blue Water acquires sexual health drug Entadfi from Miami biopharma firm Veru


Cincinnati biopharma firm Blue Water Vaccines has acquired sexual health drug Entadfi for $100 million.

Previous Bingo and 'guide partners': A startup rethinking primary care for elderly opens in Quincy
Next Corporate Philanthropy Awards 2023: Centene Corp. aims to transform health through giving